Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 4 institutions in 3 countries.
Lorena R SousaExperimental Pathology Laboratory, Federal University of São João del Rei (UFSJ), 400, Sebastião Gonçalves Coelho, Chanadour, Divinópolis 35501-296, MG, Brazil.
Ana Gabriela S OliveiraExperimental Pathology Laboratory, Federal University of São João del Rei (UFSJ), 400, Sebastião Gonçalves Coelho, Chanadour, Divinópolis 35501-296, MG, Brazil.
Antônio ArantesExperimental Pathology Laboratory, Federal University of São João del Rei (UFSJ), 400, Sebastião Gonçalves Coelho, Chanadour, Divinópolis 35501-296, MG, Brazil.
João Gabriel M JunqueiraInstitute of Chemistry, Federal University of Goiás (UFG), University Campus, Goiânia 74968-755, GO, Brazil.
Gerso P AlexandreInstitute of Chemistry, Federal University of Goiás (UFG), University Campus, Goiânia 74968-755, GO, Brazil.ORCID 0000-0001-9418-3706
Vanessa G P SeverinoInstitute of Chemistry, Federal University of Goiás (UFG), University Campus, Goiânia 74968-755, GO, Brazil.ORCID 0000-0001-5384-6657
Rui Manuel ReisMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, SP, Brazil.ORCID 0000-0002-9639-7940
Bonglee KimCollege of Medicine, Kyung Hee University, Seoul 02453, Republic of Korea.ORCID 0000-0002-8678-156X
Rosy I M A RibeiroExperimental Pathology Laboratory, Federal University of São João del Rei (UFSJ), 400, Sebastião Gonçalves Coelho, Chanadour, Divinópolis 35501-296, MG, Brazil.ORCID 0000-0002-7374-4743
Federal University of São João del-Rei · BRUniversidade Federal de Goiás · BRHospital de Câncer de Barretos · BRKyung Hee University · KR
Funding
Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education NRF-2020R1I1A2066868Coordenação de Aperfeicoamento de Pessoal de Nível Superior Finance Code 001Financiadora de Estudos e Projetos MCTI/FINEP/MS/SCTIE/DECIT-01/2013, FPXII-BIOPLATFundação de Amparo à Pesquisa do Estado de Minas Gerais PPM-00229-16 and APQ-00068-18National Research Foundation of Korea No. 2020R1A5A2019413
6 · The paper itself
Abstract
Glioblastoma (GBM) is an incurable primary brain tumor with a poor prognosis. Resection, radiation therapy, and temozolomide (TMZ) are insufficient to increase survival, making the treatment limited. Thus, the search for more effective and specific treatments is essential, making plants a promising source for elucidating new anti-glioblastoma compounds. Accordingly, this study investigated the effects of four fractions of hexane and ethyl acetate extract of
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Acetogenins-Rich Fractions of · full record | OpenQuestion